Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-25 @ 2:24 AM
NCT ID:
NCT00741234
Eligibility Criteria:
Inclusion criteria:
Arms A \& B:
* Patients with solid tumors in Arm A and hematologic malignancies in Arm B that is classified as intermediate 1 or greater according to the International Prognostic Scoring System (IPSS) risk category for whom therapy is indicated;
* ECOG performance status (PS) 0-2;
* Patients must have adequate non-hematologic organ system function.
Arm C:
* Patients with MDS that is classified as intermediate 1 or greater according to the International Prognostic Scoring System (IPSS) risk category for whom therapy is indicated;
* Have not been treated with azacitidine and are a candidate for treatment with azacitidine;
* ECOG performance status (PS) 0-2;
* Patients must have adequate non-hematologic organ system function.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00741234
Study Brief:
Protocol Section:
NCT00741234